Patients with genotype 1 or 3 hepatitis C virus (HCV) infection responded well to therapy with 400 mg of sofosbuvir combined with 100 mg of velpatasvir for 12 weeks, in a randomized, phase II,...
A combination of sofosbuvir and velpatasvir effectively treated all six hepatitis C virus genotypes in treatment-naive patients without cirrhosis, according to Dr. Gregory T. Everson and his...
SAN DIEGO – Empagliflozin used in conjunction with standard of care significantly improved renal outcomes in adults with type 2 diabetes, results from a large randomized trial showed.
“These...
Protection against shingles appeared to wane between the fifth and sixth years after patients with autoimmune diseases received the live herpes zoster vaccine, according to a large retrospective...
Stroke risk was 50% higher in the month after patients with autoimmune diseases developed herpes zoster, compared with the next 2-6 years, according to Dr. Leonard H. Calabrese.
“These data provide...
CHICAGO – Access to equal care decreases but does not eliminate the survival disparities between black and white patients with rectal cancer, according to investigators from the University of...
BOSTON– Colorectal cancers arising in the hindgut are more likely to have loss or mutation of the transcription factor SMAD4 than are tumors arising in the proximal two-thirds of the colon, and that...
Functional, a.k.a. “nonulcer,” dyspepsia is a challenging diagnosis and likely afflicts many more patients than we have identified in our practices. Functional dyspepsia (FD) is defined by the...
It may have come as a surprise to the approximately 60% of Americans who consume red or processed meat that the International Agency for Research on Cancer (IARC), a part of the World Health...